Possible scenario
Appeal Stay Granted
20% Chance
Liquidia secures a stay of any market-removal order while the patent case proceeds at the Federal Circuit. This would be a major near-term reprieve for Liquidia and would weaken United Therapeutics' attempt to protect its franchise immediately.
Tickers
- LQDA+10.0%
- UTHR-5.0%
Portfolio impact
S&P 5000.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.